I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Moderate Diabetic Retinopathy: Understanding Your Diagnosis and Your Options
What Is Moderate NPDR?
Moderate nonproliferative diabetic retinopathy is the second of four nonproliferative stages of diabetic eye disease. Understanding how and why retinal damage develops at this stage helps explain why this diagnosis requires serious attention, even when vision still feels normal.
Chronic high blood sugar gradually injures the tiny blood vessels that supply the retina, the light-sensitive tissue lining the back of the eye. Two key types of cells are especially vulnerable: pericytes, which support and stabilize blood vessel walls, and capillary endothelial cells, which line the inside of the vessels. When these cells are damaged over time, the vessels become weak and prone to leaking.
As this damage accumulates, the blood-retinal barrier breaks down. This barrier normally keeps fluid and proteins from seeping into retinal tissue. When it fails, fluid can collect within the retina and cause swelling. Inflammation and oxidative stress, a type of cellular injury caused by chemical imbalances in the body, accelerate this process. Over time, blood flow to portions of the retina may also diminish, a condition called retinal ischemia.
Diabetic retinopathy progresses through a sequence of nonproliferative stages, each reflecting a greater degree of vascular damage inside the eye, before potentially advancing to the proliferative stage.
- Mild NPDR: A small number of microaneurysms, which are tiny bulges in blood vessel walls, are the only finding
- Moderate NPDR: More widespread changes including hemorrhages, cotton-wool spots, and hard exudates are present, but the threshold for severe NPDR has not been reached
- Severe NPDR: Extensive hemorrhages, vein abnormalities, or widespread poor blood flow are present throughout the retina
- Very Severe NPDR: Even more advanced vascular damage with a high near-term risk of further progression
Proliferative diabetic retinopathy (PDR), the most advanced form of the disease, occurs when abnormal new blood vessels begin growing across the retinal surface. These fragile vessels bleed easily and can cause serious, potentially irreversible vision loss. Research data indicates that eyes with moderate NPDR carry approximately a 44 percent risk of developing PDR within five years, according to the American Society of Retina Specialists, which underscores why close monitoring is so important at this stage.
During a dilated eye exam, a retina specialist can identify the specific findings that define moderate NPDR. These changes confirm that retinal blood vessels are weakening and becoming unstable.
- Microaneurysms: More numerous than in mild NPDR, these are small outpouchings in the walls of damaged capillaries
- Dot-and-blot hemorrhages: Small areas of bleeding within the layers of the retina
- Cotton-wool spots: Fluffy, pale patches caused by disrupted blood flow to small areas of retinal tissue
- Hard exudates: Yellowish deposits left behind when fats and proteins leak from damaged blood vessels into the retina
Who Is Affected and What Increases Risk?
Diabetic retinopathy is among the most common complications of diabetes and a leading cause of vision impairment in working-age adults. Knowing the risk factors can help explain why some individuals are more likely to develop moderate NPDR and why some progress more quickly than others.
Approximately 9.6 million people in the United States are living with some form of diabetic retinopathy, representing more than one in four adults with diabetes, according to the CDC Vision and Eye Health Surveillance System. It remains one of the most significant causes of preventable vision loss in the country, making early detection and consistent follow-up essential for anyone with diabetes.
The two most influential risk factors are how long a person has had diabetes and how well blood sugar has been managed over that time. According to the National Eye Institute, after 20 years of living with diabetes, approximately 99 percent of patients with type 1 diabetes and around 60 percent of those with type 2 diabetes show some degree of retinopathy. Elevated HbA1c levels, which reflect average blood sugar over several months, directly accelerate damage to the retinal blood vessels.
Beyond blood sugar levels and duration of diabetes, several other conditions increase the likelihood of developing or worsening moderate NPDR. Some are manageable with medical care and lifestyle changes, while others are not.
- High blood pressure (hypertension), which places additional strain on already fragile retinal vessels
- Elevated cholesterol and abnormal lipid levels (dyslipidemia)
- Kidney disease related to diabetes (diabetic nephropathy), which often signals broader vascular damage throughout the body
- Smoking, which restricts oxygen delivery to tissues and worsens blood vessel health
- Pregnancy, which can accelerate the progression of existing retinopathy
Any person with type 1 or type 2 diabetes can develop diabetic retinopathy, but some individuals face a meaningfully higher risk. Those who have lived with diabetes for many years, anyone with poorly controlled blood sugar, and people who already have other diabetes-related complications should be especially attentive about regular retinal exams. Women with diabetes who are pregnant or planning a pregnancy should receive a dilated eye exam early in pregnancy and maintain close monitoring throughout, as hormonal and cardiovascular changes during pregnancy can speed retinopathy progression.
Symptoms and Warning Signs
One of the most challenging aspects of moderate NPDR is that it frequently develops without any symptoms that you can see or feel. The changes occurring in the retina can be significant even when vision appears completely unchanged.
The vascular damage in moderate NPDR typically involves the peripheral and mid-peripheral retinal blood vessels first. Until that damage reaches the central retina or causes fluid to collect beneath the macula, which is the central, detail-seeing portion of the retina, most people notice nothing unusual. This silent nature is precisely why routine dilated eye exams are critical for every person with diabetes, regardless of how normal vision may feel.
If diabetic macular edema (swelling in the central retina caused by fluid leakage) develops, or if the condition begins to advance, some patients do notice changes. These symptoms can vary widely from person to person.
- Blurred vision that may come and go or remain persistent
- Floaters, which appear as spots, strings, or drifting shadows in the field of vision
- Dark or empty patches in the visual field
- Reduced ability to see clearly in dim light or at night
- Vision that varies noticeably from day to day
Certain vision changes can signal a serious complication that requires immediate evaluation. If you experience any of the following, contact a retina specialist right away or go to an emergency room.
- A sudden and significant increase in floaters
- Flashing lights in your field of vision
- A shadow, curtain, or dark veil spreading across part of your visual field
- Sudden loss of vision in one eye
These symptoms may indicate a retinal detachment or a vitreous hemorrhage, which is bleeding inside the eye. Both are medical emergencies. Do not wait to see whether symptoms resolve on their own, as prompt treatment can make a critical difference in the outcome.
How Moderate NPDR Is Diagnosed
Diagnosing and tracking moderate NPDR requires specialized examination and imaging techniques available through a dedicated retina practice. A thorough evaluation gives your care team the information needed to make sound decisions about monitoring frequency and treatment timing.
The foundation of any diabetic retinopathy evaluation is a comprehensive dilated eye exam. Dilating drops are placed in the eyes to widen the pupils, giving the retina specialist a direct and unobstructed view of the retina, optic nerve, and macula. The specialist looks for the hallmark findings of moderate NPDR, including microaneurysms, hemorrhages, cotton-wool spots, and hard exudates. This exam cannot be substituted by a vision screening, a standard eye chart test, or retinal photography alone.
Optical coherence tomography (OCT) is a noninvasive imaging technology that produces highly detailed, cross-sectional images of the retina, layer by layer. It allows the retina specialist to measure retinal thickness with precision and detect fluid or swelling that may not be visible during a standard exam. OCT is especially valuable for identifying diabetic macular edema at an early stage, often before it causes any noticeable vision changes. The test is quick, painless, and requires no injections or contact with the eye surface.
Fluorescein angiography uses a contrast dye to create detailed maps of the retinal blood vessels. A small amount of fluorescein dye is injected into a vein in the arm, and as it circulates through the retinal circulation, a specialized camera captures rapid sequential photographs. This imaging reveals areas of leaking vessels, zones of poor blood flow (ischemia), and the distribution of microaneurysms throughout the retina. The results help the retina specialist assess disease severity and guide decisions about treatment timing.
Standard retinal photography captures only a limited portion of the retinal surface. Wide-field imaging technology extends that view significantly, capturing up to 200 degrees of the retina in a single image. This broader perspective is particularly valuable for detecting damage in the peripheral retina that could easily be missed with traditional cameras. Peripheral vascular changes can influence how moderate NPDR is staged and how urgently follow-up is recommended.
Treatment and Management
Treatment decisions for moderate NPDR are individualized and depend on factors including whether macular edema is present, how well systemic health is controlled, and how the condition appears to be changing over time. Your retina specialist will work with you and your other physicians to develop a plan suited to your specific situation.
For moderate NPDR, the most impactful intervention is often not an eye procedure but improved control of the underlying diabetes. Research supported by the National Eye Institute has consistently demonstrated that keeping HbA1c at or below 7 percent meaningfully reduces the risk of retinopathy worsening. Blood pressure control and cholesterol management are equally important, since both conditions directly affect the health and stability of retinal blood vessels.
Working closely with your primary care physician or endocrinologist to optimize blood sugar, blood pressure, and lipid levels is not secondary to your eye care. It is central to it. These systemic improvements create the foundation for any eye treatment to be most effective.
For patients with moderate NPDR who do not have diabetic macular edema, careful observation is typically the recommended approach. Follow-up visits are generally scheduled every six to eight months, during which imaging and examination allow the retina specialist to track changes and intervene promptly if the disease advances.
Research estimates that patients with moderate NPDR face a 12 to 27 percent risk of progressing to proliferative diabetic retinopathy within one year, and approximately 23 percent progress to proliferative stages within four years. These figures make consistent follow-up not a suggestion but a clinical necessity, even when vision remains unchanged between visits.
Anti-VEGF therapy involves medications that block vascular endothelial growth factor (VEGF), a protein that drives abnormal blood vessel growth and leakage in the retina. These medications are delivered through an intravitreal injection, meaning they are administered directly into the eye in a brief, in-office procedure. The eye is numbed with anesthetic drops beforehand, and the injection itself takes only a few seconds. Most patients describe a sensation of pressure rather than sharp pain, and any mild irritation afterward typically resolves within one to two days.
Anti-VEGF injections are the standard treatment for diabetic macular edema and are used for more advanced stages of diabetic retinopathy as well. Clinical research has demonstrated that anti-VEGF therapy can not only reduce retinal swelling but also improve the overall severity of diabetic retinopathy on standardized grading scales for a meaningful proportion of patients. For select cases of moderate NPDR, particularly when there is concern about rapid progression, your retina specialist may discuss this option with you.
Laser photocoagulation uses a focused laser beam to seal leaking blood vessels or treat areas of poor blood flow in the retina. It has been a mainstay of diabetic retinopathy treatment for decades. In moderate NPDR without macular edema, laser treatment is generally not indicated as an initial approach. However, if the disease advances to more severe nonproliferative or proliferative stages, laser therapy may become part of the treatment plan. A retina specialist will determine whether and when laser treatment is appropriate based on your individual disease course and examination findings.
Living With Moderate NPDR
A diagnosis of moderate NPDR calls for active engagement in your own care. The choices you make every day, from how consistently you manage your blood sugar to whether you attend your scheduled eye exams, have a direct and measurable effect on how this condition evolves over time.
Maintaining well-controlled blood sugar is the single most effective tool available for protecting your vision with moderate NPDR. Even after retinal changes have already developed, improved glycemic control can slow further damage and reduce the likelihood of needing more intensive treatment. Monitoring blood sugar regularly, taking all prescribed medications as directed, and staying engaged with your diabetes care team are all essential steps in preserving your sight.
High blood pressure places added strain on retinal blood vessels that are already compromised by diabetes. Keeping blood pressure within a healthy range, guided by your primary care physician, helps protect those vessels from further injury. Managing cholesterol and lipid levels supports overall vascular health and reduces the risk of complications in the eyes and throughout the body. These systemic targets are as relevant to your retinal health as any eye-specific treatment.
Healthy daily habits reinforce the medical management of moderate NPDR and support long-term metabolic stability. Regular physical activity helps regulate blood sugar, blood pressure, and body weight. A balanced diet rich in vegetables, whole grains, lean protein, and healthy fats reduces metabolic strain. If you currently smoke, stopping is one of the most impactful steps you can take for both your vascular and eye health, and support is available through your primary care team to help you quit.
Learning that your diabetic retinopathy has progressed to a moderate stage can be unsettling, and it is completely understandable to feel anxious or concerned about your future vision. Staying informed, asking questions openly at each visit, and attending all scheduled appointments can help you feel more in control of an uncertain situation. Many patients find that connecting with diabetes support groups or speaking with a counselor helps them manage the emotional side of living with a progressive condition. You do not have to navigate this alone.
Frequently Asked Questions
The following answers address questions we commonly hear from patients with moderate NPDR, offering additional context and practical guidance beyond what is covered in detail above.
In some patients, the severity of diabetic retinopathy can genuinely improve with rigorous blood sugar control or anti-VEGF treatment. Clinical research has demonstrated that anti-VEGF therapy results in meaningful improvement on standardized diabetic retinopathy severity scales for a meaningful proportion of patients who receive it. However, improvement is not guaranteed and depends heavily on individual factors, including how consistently systemic health is optimized. For many patients, stabilization rather than reversal is the more realistic and still highly valuable goal, because stopping progression protects vision over the long term.
Yes, and this is one of the most important points to understand about moderate NPDR. The condition frequently causes no symptoms at all while retinal changes continue to worsen. Vision can remain normal while vascular damage reaches a point where more aggressive treatment will soon be needed. Skipping scheduled visits creates a gap during which treatable progression may go undetected. Regular monitoring is the only reliable way to catch changes early enough to intervene most effectively.
Intravitreal injections are performed in the office using numbing drops applied to the eye surface beforehand, so the procedure is much more comfortable than most patients expect. The injection itself takes only a few seconds. Most patients describe a sensation of mild pressure, not sharp pain. Afterward, there may be mild redness, a foreign body sensation, or slightly blurred vision for a day or two, all of which typically resolve on their own. Your retina specialist will walk you through every step before the procedure and answer any questions you have.
Monitoring is an ongoing commitment for as long as you have diabetes. Even if your retinopathy stabilizes or shows improvement, the underlying risk associated with diabetes remains present. Your retina specialist will adjust the frequency of visits based on your individual stability, the presence or absence of macular edema, and how well your systemic health is controlled. Some patients with stable, well-managed disease may transition to annual exams, while others with more active disease will be seen more frequently. There is no fixed endpoint; the schedule evolves with your health.
For the vast majority of people with moderate NPDR, regular moderate exercise is not only safe but actively beneficial. Physical activity helps regulate blood sugar, lower blood pressure, and support cardiovascular health, all of which have a positive effect on retinal blood vessel stability. If your retinopathy advances to a more severe or proliferative stage, or if you develop other complications, your retina specialist may offer specific activity guidance tailored to your situation. In general, staying physically active is an important part of managing diabetic eye disease, not something to avoid.
Contact us or go to an emergency room immediately if you experience a sudden increase in floaters, flashes of light in your vision, a dark shadow or curtain moving across your field of view, or sudden loss of vision in one eye. These symptoms can indicate a retinal detachment or bleeding inside the eye, both of which are medical emergencies that require urgent evaluation. Waiting even a day or two in these situations can affect the outcome of treatment. If you are ever uncertain whether a symptom warrants urgent care, it is always safer to call and ask than to wait.
Expert Retina Care When It Matters Most
At New England Retina Associates, our fellowship-trained vitreoretinal specialists provide focused, experienced care for every stage of diabetic eye disease, from early detection through advanced treatment. If you or someone you care for has been diagnosed with moderate NPDR, or if you have diabetes and have not had a recent dilated eye exam, we encourage you to schedule an evaluation with our team. Patients across Connecticut rely on us for thorough, compassionate retina care, and we are here to help you protect your vision for the long term.
30 Years of Care & Commitment
